Author:
Serra Carla,Praticò Chiara,Cappelli Alberta
Reference49 articles.
1. Magro F, Gionchetti P, Eliakim R et al; European Crohn’s and Colitis Organisation [ECCO] (2017) Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis 11(6):649–670
2. Panes J, Bouhnik Y, Reinisch W et al (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 7(7):556–585
3. Jalan KN, Sircus W, Card WI et al (1969) An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroenterology 57(1):68–82
4. Benchimol EI, Turner D, Mann EH et al (2008) Toxic megacolon in children with inflammatory bowel disease: clinical and radiographic characteristics. Am J Gastroenterol 103(6):1524–1531
5. Norland CC, Kirsner JB (1969) Toxic dilatation of colon (toxic megacolon): etiology, treatment and prognosis in 42 patients. Medicine (Baltimore) 48(3):229–250